Surgery is the mainstay of treatment for cardiac<unk> . The feasibility of surgery depends on the patient hemodynamic stability at diagnosis. Cardiac<unk>  has an operative mortality around 0 to 3%, depending on risk factors or mechanical damage to a heart valve, as well as adhesion of the tumor to valve leaflets. The short and long-term prognosis is generally regarded as excellent.
Myxoma surgery
Warthin's tumor surgery
Oligoastrocytoma surgery
Germinoma surgery
Ependymoma surgery
Neurofibroma surgery
Malignant peripheral nerve sheath tumor surgery
Schwannoma surgery